Format

Send to

Choose Destination
Mod Rheumatol. 2013 Sep;23(5):841-5. doi: 10.1007/s10165-012-0788-5. Epub 2012 Nov 8.

Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.

Author information

1
Department of Internal Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan, tsumida@md.tsukuba.ac.jp.

Abstract

Sjögren's syndrome (SS) is an autoimmune disease that affects exocrine glands including salivary and lacrimal glands. Recently, autoantibodies against muscarinic acetylcholine receptor M3 (M3R) have been detected in serum from 9 to 100 % of patients with SS in addition to anti-SS-A and anti-SS-B antibodies. These observations suggest the possibility that anti-M3R antibodies could serve as a new diagnostic test in patients with SS. Some anti-M3R antibodies are directly responsible for salivary underproduction in patients with SS. Thus, strategies designed to eliminate such pathogenic antibodies could help cure SS sufferers. In this review, we summarize the current state of knowledge of anti-M3R autoantibodies in patients with SS and the correlation between B cell epitopes and the function of anti-M3R antibodies.

PMID:
23135882
DOI:
10.1007/s10165-012-0788-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center